Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults (clinicaltrials.gov) - Aug 24, 2023 - P3 | N=1831 | Completed | Sponsor: Clover Biopharmaceuticals AUS Pty Ltd | Active, not recruiting ➔ Completed | Trial completion date: Feb 2024 ➔ Jun 2023
Trial completion • Trial completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
|